Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Roberta Celleno"'
Autor:
Milena Sira Zanon, Paolo Di Bartolo, Francesco Pio Tripodi, Chiara Molinari, Federico Bertuzzi, Marina Scavini, Giuliana La Penna, Roberta Celleno, Angela Girelli
Publikováno v:
Acta Diabetologica. 56:1235-1238
Autor:
Roberta Celleno, Paola Lucidi, Elena Volpi, Stefano Laureti, Stefania Santoni, Marco Lauteri, Pierpaolo De Feo, Fausto Santeusanio, Gabriella Angeletti
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 83:353-357
This study was designed to establish the lower dose of effective GH replacement therapy in severe GH-deficient (GHD) adults. Whole body protein and lipid kinetics were determined in six GHD men in the basal state (B) and after 1 week of treatment wit
Autor:
Alfonso, Iorio, Marco Orsini, Federici, Evangelia, Mourvaki, Piero, Ferolla, Marta, Piroddi, Anna, Stabile, Alessandra, Timi, Roberta, Celleno, Massimo Massi, Benedetti
Publikováno v:
Thrombosis and haemostasis. 98(3)
Review of literature has shown an increased rate of thrombotic complications in diabetic patients with frequent episodes of hyperketonemia. However, the mechanisms by which ketosis promotes vascular disease in diabetic patients are unclear. It was th
Autor:
Gabriella Angeletti, Giovanni Gilardi, Roberta Celleno, Natalina Manci, G. Baiocchi, Daniela Fratini
A 58-year-old postmenopausal woman with high plasma testosterone levels and virilization, as demonstrated by hirsutism and alopecia, is presented. Urinary 17-ketosteroids and 17-hydroxycorticosteroids as well as the computed axial tomography scan of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06742eb988f13a0692363698d96aa189
http://hdl.handle.net/11391/1032274
http://hdl.handle.net/11391/1032274
Autor:
F. Ragazzoni, Silvia Grottoli, Davide Caramella, Gabriella Angeletti, Francesca Pigliaru, Roberta Celleno, Rosario Pivonello, Valentina Gasco, D. Alberti, Antonella Barreca, Roberto Ferrara
Publikováno v:
Scopus-Elsevier
The aim of the present multicentric, open-label, non-comparative study was to evaluate the role of octreotide long-acting repeatable (LAR) as primary therapy for the treatment of GH-secreting pituitary macroadenomas. The patients received octreotide
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a3dac8e5cff527eba23cc960806e85f
http://www.scopus.com/inward/record.url?eid=2-s2.0-33144456938&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-33144456938&partnerID=MN8TOARS